Bellicum Pharmaceuticals, Inc. (BLCM) financial statements (2021 and earlier)

Company profile

Business Address 3730 KIRBY DRIVE
HOUSTON, TX 77098
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:355366759110343
Cash and cash equivalents35536675919943
Short-term investments     414
Other undisclosed cash, cash equivalents, and short-term investments      (14)
Restricted cash and investments2 013  
Assets held-for-sale, not part of disposal group2  1717  
Other undisclosed current assets11221216
Total current assets:3954689411210559
Noncurrent Assets
Operating lease, right-of-use asset1111166
Property, plant and equipment032231618
Restricted cash and investments 22  44
Other noncurrent assets0001133
Total noncurrent assets:164342931
TOTAL ASSETS:4160729811613490
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:4778101413
Employee-related liabilities1222253
Other undisclosed accounts payable and accrued liabilities34578910
Deferred revenue     11
Debt 106111186
Derivative instruments and hedges, liabilities102428155238 
Restructuring reserve     3 
Other undisclosed current liabilities1029372421122
Total current liabilities:25697959947622
Noncurrent Liabilities
Long-term debt and lease obligation 18212426 6
Long-term debt, excluding current maturities 18212426  
Operating lease, liability      6
Other undisclosed noncurrent liabilities011113531
Total noncurrent liabilities:0192124273537
Total liabilities:25871008312111159
Temporary equity, carrying amount182121212122 
Stockholders' equity
Stockholders' equity attributable to parent(2)(48)(49)(7)(26)130
Common stock0000110
Treasury stock, value(5)(5)(5)(5)(5)(5)(5)
Additional paid in capital544517515514512510507
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Accumulated deficit(541)(560)(559)(515)(533)(504)(472)
Total stockholders' equity:(2)(48)(49)(7)(26)130
TOTAL LIABILITIES AND EQUITY:4160729811613490

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues2000501
Net investment income 000000
Cost of revenue
(Cost of Goods and Services Sold)
      (0)
Other undisclosed gross profit    0  
Gross profit:2000501
Operating expenses(12)(12)(16)(15)(19)(24)(28)
Other undisclosed operating income (loss)(3)(0)4(0)(0)(0)0
Operating loss:(13)(12)(12)(15)(14)(23)(26)
Nonoperating income (expense)3211(31)32(15)(9)(1)
Other nonoperating expense   (3)(0)(3) 
Interest and debt expense3(1)(1)(1)(1)(1)(1)
Net income (loss):21(2)(44)17(30)(33)(28)
Other undisclosed net income (loss) attributable to parent(3)111111
Net income (loss) attributable to parent:19(1)(43)18(29)(32)(27)
Undistributed earnings (loss) allocated to participating securities, basic   (12)   
Net income (loss) available to common stockholders, diluted:19(1)(43)5(29)(32)(27)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):21(2)(44)17(30)(33)(28)
Other undisclosed comprehensive loss    (113)  
Comprehensive income (loss):21(2)(44)17(143)(33)(28)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3)11111411
Comprehensive income (loss), net of tax, attributable to parent:19(1)(43)18(29)(32)(27)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: